{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:39:40Z","timestamp":1764700780954,"version":"3.44.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.humpath.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T11:41:21Z","timestamp":1588851681000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-1810","authenticated-orcid":false,"given":"Christopher M.","family":"Heaphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-0373","authenticated-orcid":false,"given":"Mindy K.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7571-306X","authenticated-orcid":false,"given":"David","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Corey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario A.","family":"Eisenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo M.","family":"De Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan K.","family":"Meeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara L.","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.04.014_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","article-title":"Structure and function of telomeres","volume":"350","author":"Blackburn","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2020.04.014_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrm2848","article-title":"Telomeres: protecting chromosomes against genome instability","volume":"11","author":"O'Sullivan","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.humpath.2020.04.014_bib3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0022-2836(92)90096-3","article-title":"Telomere end-replication problem and cell aging","volume":"225","author":"Levy","year":"1992","journal-title":"J Mol Biol"},{"key":"10.1016\/j.humpath.2020.04.014_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Canc"},{"key":"10.1016\/j.humpath.2020.04.014_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(01)00457-3","article-title":"Telomere dysfunction increases mutation rate and genomic instability","volume":"106","author":"Hackett","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2020.04.014_bib6","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/j.1460-2075.1992.tb05245.x","article-title":"Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity","volume":"11","author":"Counter","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.humpath.2020.04.014_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/82586","article-title":"Telomere maintenance by recombination in human cells","volume":"26","author":"Dunham","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2020.04.014_bib8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.onc.1205058","article-title":"Alternative lengthening of telomeres in mammalian cells","volume":"21","author":"Henson","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2020.04.014_bib9","first-page":"6405","article-title":"Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis","volume":"62","author":"Meeker","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/pros.22997","article-title":"Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial","volume":"75","author":"Heaphy","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2020.04.014_bib11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/2159-8290.CD-13-0135","article-title":"Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death","volume":"3","author":"Heaphy","year":"2013","journal-title":"Canc Discov"},{"key":"10.1016\/j.humpath.2020.04.014_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/PAS.0000000000000208","article-title":"Proposed morphologic classification of prostate cancer with neuroendocrine differentiation","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/modpathol.2011.7","article-title":"ERG gene rearrangements are common in prostatic small cell carcinomas","volume":"24","author":"Lotan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/PAS.0b013e318058a96b","article-title":"Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases","volume":"32","author":"Wang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1078-0432.CCR-13-1982","article-title":"Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma","volume":"20","author":"Tan","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-11-1867","article-title":"Modeling a lethal prostate cancer variant with small-cell carcinoma features","volume":"18","author":"Tzelepi","year":"2012","journal-title":"Clin Canc Res : an Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.humpath.2020.04.014_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.humpath.2020.04.014_bib19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-13-2921-T","article-title":"High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development","volume":"74","author":"Lin","year":"2014","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/pros.20910","article-title":"Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate","volume":"69","author":"Hansel","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2020.04.014_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/s12885-017-3729-z","article-title":"Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma","volume":"17","author":"Tsai","year":"2017","journal-title":"BMC Canc"},{"key":"10.1016\/j.humpath.2020.04.014_bib22","doi-asserted-by":"crossref","first-page":"22772","DOI":"10.18632\/oncotarget.15196","article-title":"Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers","volume":"8","author":"Lotan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2020.04.014_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2019.02.006","article-title":"TP53 missense mutation is associated with increased tumor-infiltrating T-cells in primary prostate Cancer","volume":"87","author":"Kaur","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/01.pas.0000213447.16526.7f","article-title":"Immunohistochemical antibody cocktail staining (p63\/HMWCK\/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate","volume":"31","author":"Herawi","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib25","article-title":"Clinical Outcomes and molecular characterization of clinically localized very high risk (primary Gleason score of 5) prostate cancer after radical prostatectomy","volume":"3","author":"Isaacsson Velho","year":"2019","journal-title":"J Clin Oncol Precis Med"},{"key":"10.1016\/j.humpath.2020.04.014_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41391-017-0027-4","article-title":"p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer","volume":"21","author":"Maughan","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.humpath.2020.04.014_bib27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pros.23313","article-title":"LuCaP prostate cancer patient-derived xenografts reflect the molecular heterogeneity of advanced disease an--d serve as models for evaluating cancer therapeutics","volume":"77","author":"Nguyen","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2020.04.014_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0002-9440(10)64226-5","article-title":"A neuroendocrine\/small cell prostate carcinoma xenograft-LuCaP 49","volume":"161","author":"True","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/modpathol.2010.198","article-title":"Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes","volume":"24","author":"Heaphy","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.humpath.2015.05.001","article-title":"Telomere length alterations unique to invasive lobular carcinoma","volume":"46","author":"Heaphy","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib31","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/pros.22755","article-title":"Telomere length as a risk factor for hereditary prostate cancer","volume":"74","author":"Hurwitz","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2020.04.014_bib33","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1541-7786.MCR-19-0654","article-title":"Functional loss of ATRX and TERC activates alternative lengthening of telomeres (ALT) in LAPC4 prostate cancer cells","volume":"17","author":"Graham","year":"2019","journal-title":"Mol Canc Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib34","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/pros.23042","article-title":"PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas","volume":"75","author":"Morais","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2020.04.014_bib35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/modpathol.2016.88","article-title":"Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH","volume":"29","author":"Lotan","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib36","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/PAS.0b013e31821e8761","article-title":"Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas","volume":"35","author":"Chaux","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib37","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/1078-0432.CCR-17-0257","article-title":"Analytic, preanalytic, and clinical validation of p53 IHC for detection of TP53 missense mutation in prostate cancer","volume":"23","author":"Guedes","year":"2017","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib38","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","article-title":"Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes","volume":"179","author":"Heaphy","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2020.04.014_bib40","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"130","author":"Labrecque","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2020.04.014_bib41","article-title":"Molecular characterization and clinical outcomes of primary Gleason pattern 5 prostate cancer after radical prostatectomy","volume":"3","author":"Velho","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.humpath.2020.04.014_bib42","first-page":"1306","article-title":"Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts","volume":"62","author":"Vaziri","year":"1997","journal-title":"A review. Biochemistry (Mosc)"},{"key":"10.1016\/j.humpath.2020.04.014_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrurol.2017.104","article-title":"Telomeres and telomerase in prostate cancer development and therapy","volume":"14","author":"Graham","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.humpath.2020.04.014_bib44","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/sj.onc.1206227","article-title":"Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma","volume":"22","author":"Vukovic","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2020.04.014_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ccr.2007.02.026","article-title":"Short telomeres limit tumor progression in vivo by inducing senescence","volume":"11","author":"Feldser","year":"2007","journal-title":"Canc Cell"},{"key":"10.1016\/j.humpath.2020.04.014_bib46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/carcin\/bgn050","article-title":"Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer","volume":"29","author":"Perera","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2020.04.014_bib47","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnci\/87.12.895","article-title":"Telomerase activity in small-cell and non-small-cell lung cancers","volume":"87","author":"Hiyama","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2020.04.014_bib48","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/carcin\/20.8.1649","article-title":"Is small cell lung cancer the perfect target for anti-telomerase treatment?","volume":"20","author":"Sarvesvaran","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2020.04.014_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/path.1401","article-title":"Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping","volume":"201","author":"Zaffaroni","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2020.04.014_bib50","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/sj.bjc.6601643","article-title":"Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours","volume":"90","author":"Lantuejoul","year":"2004","journal-title":"Br J Canc"},{"key":"10.1016\/j.humpath.2020.04.014_bib51","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1158\/1078-0432.CCR-04-1293","article-title":"Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres","volume":"11","author":"Zaffaroni","year":"2005","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-014-0047-7","article-title":"High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins","volume":"7","author":"Zheng","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.humpath.2020.04.014_bib53","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/1055-9965.EPI-12-0042","article-title":"The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis","volume":"21","author":"Pettersson","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2020.04.014_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2020.04.014_bib55","first-page":"1239","article-title":"Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription","volume":"6","author":"Kanaya","year":"2000","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.04.014_bib56","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/sj.onc.1203890","article-title":"Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells","volume":"19","author":"Xu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2020.04.014_bib57","doi-asserted-by":"crossref","first-page":"50976","DOI":"10.1074\/jbc.M402502200","article-title":"p53-dependent down-regulation of telomerase is mediated by p21waf1","volume":"279","author":"Shats","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2020.04.014_bib58","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1172\/JCI70354","article-title":"Tracking the clonal origin of lethal prostate cancer","volume":"123","author":"Haffner","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:11Z","timestamp":1758645431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720300861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":58,"alternative-id":["S0046817720300861"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.04.014","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}